Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2010The OncologistOpen Access

Uncertainty in Assessing Value of Oncology Treatments

View Full Paper
Ask AI
Bookmark
Share

Authors

CMC. Daniel MullinsUniversity of Maryland, BaltimoreRMRuss MontgomeryUniversity of Maryland, BaltimoreSTSean TunisUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mullins et al. (2010) studied this question.

synapsesocial.com/papers/6a7b628ea51ded8e7b331f7ahttps://doi.org/10.1634/theoncologist.2010-s1-58
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction2003 · 142 citations
  2. 2Rethinking Health Numeracy: A Multidisciplinary Literature Review2007 · 274 citations
  3. 3Association of progression‐free survival, overall survival, and patient‐reported outcomes by skin toxicity and <i>KRAS</i> status in patients receiving panitumumab monotherapy2009 · 135 citations
  4. 4Systematic Review: Reliability of Compendia Methods for Off-Label Oncology Indications2009 · 96 citations